EverSource Wealth Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

EverSource Wealth Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12	Closed	-$477	–	4419
2026 Q1	$477	Buy	12 +5	+71%	+$128	﹤0.01%	4076
2025 Q4	$175	Sell	7 -13	-65%	-$329	﹤0.01%	4045
2025 Q3	$485	Hold	20	–	–	﹤0.01%	3960
2025 Q2	$263	Buy	+20	New	+$253	﹤0.01%	4018

EverSource Wealth Advisors's CNTA Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 12 shares — an estimated $477 sold.

EverSource Wealth Advisors first reported a position in CNTA in Q2 2025 and held it in 4 quarters. The position peaked at $485 in Q3 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

EverSource Wealth Advisors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 12 Centessa Pharmaceuticals shares in Q2 2026, an estimated $477.
EverSource Wealth Advisors first reported a position in Centessa Pharmaceuticals in Q2 2025 and held it in 4 quarters.
EverSource Wealth Advisors's Centessa Pharmaceuticals position peaked at $485 in Q3 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.